Skip to content
healthcare.dev
Get a free key

Insulin Aspart Protamine and Insulin Aspart Mix 70/30

NDC 73070-203, insulin aspart, injection, suspension, from Novo Nordisk Pharma, Inc..

Product NDC
73070-203
Status
Listed
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021172
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73070-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN ASPART100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
73070-203-15730700203155 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fc94baa4-3606-48bc-a781-9617ab6960ef

  • NADAC price for package 73070020315

    GET /v1/drugs/nadac/73070020315

Use it

Look up 73070-203 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73070-203 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73070-203. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.